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1. Introduction
Mast cells and basophils play major roles in allergic responses of the immediate type (Rivera
& Gilfillan, 2006). Allergic individuals produce IgE that is specific for the multivalent foreign
molecules (allergens) that trigger their allergic responses. IgE binds with high affinity through
its constant region to a monovalent receptor, FcǫRI, that is expressed on the surface of
basophils and mast cells and that mediates much of mast cell activation in allergic reactions.
Upon exposure to the allergen, the bridging of multiple IgEs by the allergen results in
the aggregation of FcǫRI receptors on the cell surface, which in turn triggers a cascade
of biochemical reactions that results in the release of preformed mediators from granules
together with the synthesis and release of lipid mediators and cytokines. The cytosolic protein
tyrosine kinase Syk plays a crucial role in FcǫRI-mediated signaling cascade in mast cells.
A clone of the syk gene was first isolated on the basis of partial sequenced information of
a 40 kDa kinase from porcine spleen (de Castro, 2011; Taniguchi et al., 1991). The product
of this gene was identified as a nonreceptor-type protein tyrosine kinase of 72 kDa (Yang
et al., 1994) and was named Spleen Tyrosine Kinase (Syk). Syk has two Src-homology 2
domains (SH2) which are separated by a linker region from the kinase domain (Siraganian
et al., 2002). FcǫRI is a tetrameric complex composed of an α-chain that binds IgE to form a
long-lived complex, and three subunits, a β-chain and two disulfide-linked γ-chains (Blank
et al., 1989) that contain immunoreceptor tyrosine-based activation motifs (ITAMs). The FcǫRI
receptor lacks intrinsic enzymatic acitivity and requires non-receptor protein tyrosine kinase
activity in propagating cellular signals in allergen-stimulated mast cells and basophils. The
unphosphorylated β-chain of the FcǫRI receptor associates weakly with the Src family kinase
Lyn, which is anchored to the inner layer of the plasma membrane (Vonakis et al., 1997;
2001). Upon receptor aggregation, Lyn transphosphorylates tyrosines in the β and γ ITAMs.
Syk from the cytosol binds with high affinity through its two SH2 domains to the doubly
phosphorylated γ ITAM (Benhamou et al., 1993; Hutchcroft et al., 1992). Recent experimental
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findings (de Castro et al., 2010; Siraganian et al., 2010) indicate that the binding of Syk to
phosphorylated γ ITAM causes a conformational change of the Syk molecule and enhances
its enzymatic activity. The conformation change of the activated Syk molecule exposes its
COOH-terminal region, thereby enabling the phosphorylation of two conserved tyrosines
(Tyr-624 and Tyr-625 in rat Syk). These two phosphotyrosines maintain the γ ITAM bound
Syk in an open conformation, which allows the phosphorylation on multiple tyrosines by
both Lyn and Syk (Siraganian et al., 2002), with a second Syk molecule playing the major role
in transphosphorylating two tyrosines, Tyr-519 and Tyr-520, in the Syk activation loop (Zhang
et al., 2000; 1998). This yields a fully activated Syk that phosphorylates the adaptor proteins
LAT (Linker for Activation of T cells) and NTAL (Non-T-cell Activation Linker) that function
as scaffolds, organizing other signaling proteins that are responsible for signaling events
further downstream (Rivera, 2005). The phosphorylation of the two tyrosine residues in the
activation loop of Syk is critical to the propagation of FcǫRI signaling, since the substitution of
these tyrosines by phenylalanine abrogates signaling and degranulation in mast cells (Zhang
et al., 1998).
In order to predict the strength of the allergen-induced signaling in mast cells and basophils,
it is important to understand the subtle kinetic effects underlying Syk activation, and how
these kinetic effects influence the level of Syk activation, since this event couples the initial
signaling events in the cascade with the downstream signaling events. Although many
of the biochemical reactions leading from Syk activation to histamine release have been
investigated in great detail, a complete model of the signaling cascade still eludes us. A
detailed mathematical model of the early signaling events, up to and including Syk activation,
that are triggered when IgE-FcǫRI complexes are exposed to a bivalent or trivalent ligand on
rat basophilic leukemia (RBL) cells has been developed by Faeder et al. (2003). In the model,
full activation of a Syk molecule requires its transphosphorylation by a second Syk molecule,
the two Syk molecules being bound to different receptors in a receptor dimer (Zhang et al.,
2000). In this chapter, we review our research (Nag, Faeder & Goldstein, 2010; Nag, Monine,
Blinov & Goldstein, 2010) on the exploration of the different factors that influence the kinetics
and the level of Syk activation in stimulated mast cells and basophils using the mathematical
model of Faeder et al. (2003).
First, we use the model of Faeder et al. (2003) to investigate investigate the effects of the
extracellular allergen concentration and the cellular FcǫRI and Syk expression levels on
the extent of Syk activation. Using model simulations, we explore how the extent of Syk
activation varies as a function of the concentration of the allergen, for given FcǫRI and Syk
concentrations, and for a given set of kinetic parameters characterizing binding, unbinding,
phosphorylation and dephosphorylation events (Nag, Faeder & Goldstein, 2010).
For bivalent allergens binding to the monovalent IgE-FcǫRI complex, a plot of the equilibrium
concentration of receptors in aggregates versus the log of the free allergen concentration,
the cross-linking curve, is symmetric and bell-shaped. One might naively expect that the
variation of Syk activation with the equilibrium allergen concentration should be qualitatively
similar to the variation in the number of cross-linked FcǫRI receptors. We define the Syk
activation curve as a plot of the number of fully activated Syk molecules in a cell versus the
log of the equilibrium free allergen concentration. Our model predicts that if the mechanism
by which Syk is fully activated involves the transphosphorylation of Syk by Syk, then Syk
activation curves can be either bell-shaped or double humped, depending on the relative
cellular concentrations of Syk and FcǫRI. For many physiological Syk expression levels, the
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predicted Syk activation curve follows the receptor cross-linking curve. However, for limiting
Syk concentration, an excess of cross-linked receptors over Syk molecules over a range of
free equilibrium allergen concentrations can occur and result in high-dose inhibition of Syk
activation (Hlavacek et al., 2003). At other allergen concentrations, the extent of cross-linking
is lower so that there is enough Syk for two Syk molecules to be bound to the same receptor
dimer. This predicted differential behavior at different allergen concentrations gives rise to
the variable shape (unimodal/multimodal) of the Syk activation curve (Hlavacek et al., 2003).
More interestingly, for some reasonable parameter regimes, the bimodal Syk activation curves
can be non-symmetric with respect to the ligand concentration. We discuss how, even though
it is only receptor aggregates that trigger responses, differences in total ligand concentration,
that are not reflected in the extent of receptor aggregation, can lead to subtle kinetic effects
that yield qualitative differences in the levels of Syk activation.
Secondly, we use our mathematical model to evaluate the role of serial engagement (Davis,
1995; Valitutti et al., 1995) in Syk activation in mast cells (Nag, Monine, Blinov & Goldstein,
2010). The terms serial triggering and serial engagement were introduced in immunology
when Valitutti et al. (Davis, 1995; Valitutti et al., 1995) reported that within the contact area
between an antigen presenting cell (APC) and a T cell, a few antigenic peptides bound to major
histocompatibility complex molecules (pMHC) mediated the internalization of hundreds of T
cell receptors (TCRs). The concept of serial engagement was introduced to describe the ability
of a single peptide, bound to a MHC molecule, to sequentially interact with TCRs within the
contact region between a T cell and an APC.
The observation that TCRs undergo serial engagement, coupled with the kinetic proofreading
model for cell signaling (Goldstein et al., 2008; McKeithan, 1995), led to the hypothesis
that for T cell activation there should be an optimal range of half-lives for the pMHC-TCR
bond (Lanzavecchia et al., 1999). The basic idea of kinetic proofreading is that for a TCR to
become activated it must remain associated with a pMHC long enough for a set of biochemical
modifications to occur. In case of dissociation of the pMHC from the TCR before the necessary
modifications have been completed, signaling is frustrated and activation is not achieved.
In order to obtain a measurable signaling response from a T cell, multiple TCRs must be
activated. Therefore, at low pMHC density, a single pMHC needs to trigger multiple TCR
before it diffuses out of the contact region. If the pMHC dissociates too rapidly it will
encounter many TCRs but activate only a few. On the other hand, if it remains bound too
long it will activate those it encounters but the frequency of encounters will be small. The
recognition that the pMHC-TCR bond half-life has opposing effects on kinetic proofreading
and serial engagement led to the prediction that to achieve an optimal rate of TCR activation
there should be an optimal half-life, or equivalently an optimal dissociation rate constant koff,
(Coombs & Goldstein, 2005; Lanzavecchia et al., 1999). Although some studies have found an
optimal half-life for T cell activation (Carreno et al., 2007; Coombs et al., 2002; Kalergis et al.,
2001), there are other results that are not consistent with this model (reviewed in (Aleksic et al.,
2010; Stone et al., 2009)).
In addition to surface ligands, soluble multivalent ligands can serially engage cell surface
receptors involving repeated binding and dissociating of ligand sites from receptors before
all ligand sites become free and the ligand leaves the surface. Although there has been a
significant effort directed at unraveling the role of serial engagement of TCRs in activating
T-cells, the role of serial engagement by soluble multivalent ligands, of other multichain
immune recognition receptors in cell activation has remained largely unexplored.
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The immunological term avidity was coined more than fifty years ago to distinguish between
the binding properties of an antibody and its monovalent Fab fragment (reviewed in (Karush,
1989)). It was observed that an IgG, at low concentrations, could bind to a surface containing
multiple binding sites (epitopes) with an apparent affinity that was orders of magnitude
greater than the equilibrium constant for binding of one of its Fab sites to an epitope
(Gopalakrishnan & Karush, 1974; Greenbury et al., 1965; Hornick & Karusch, 1972). Avidity
arises when the density of surface binding sites is sufficiently high that multivalent ligands are
observed to dissociate from the surface more slowly than their monovalent constituent parts,
thus exhibiting a high apparent affinity. When a site on a doubly bound IgG dissociates, the
epitope it was bound to will diffuse away. If this newly freed site on the IgG binds to another
epitope before its second site dissociates, the IgG will remain bound to the surface. Thus,
avidity can arise by ligands serially engaging epitopes, traversing from epitope to epitope,
along the surface.
Avidity can arise in another way that does not require serial engagement. For example,
the cross-linking IgE-FcǫRI complexes on rat basophilic leukemia (RBL) cells by a highly
multivalent antigen leads to the rapid formation of large stable aggregates of immobilized
receptors (Andrews et al., 2008; Menon et al., 1986). This observation suggests the possibility
that a site on a bound ligand can dissociate from, and rebind to the same immobilized receptor
many times, effectively increasing its off rate constant, before all its sites on the ligand become
free and the ligand dissociates from the cell. Recent multi-color tracking experiments indicate
that small aggregates of IgE-FcǫRI complexes, comprising two to four receptors, remain
mobile on the RBL surface even at ligand doses that result in degranulation (Andrews et al.,
2009).
A major difficulty in assessing the role of serial engagement of receptors in cell signaling is
that the phenomena cannot be studied in isolation. To gauge the role of serial engagement
in mast cell signaling, we use the detailed mathematical model of the early events triggered
when IgE-FcǫRI complexes are exposed to a bivalent or trivalent ligand on RBL cells (Faeder
et al., 2003). Simulations using this model has enabled us to delineate how different alterations
in the binding properties of the ligand, that result in the same rates of serial engagement of
receptors, can alter receptor activation in different ways.
2. Mathematical model
2.1 Components
We briefly review our mathematical model for the early signaling events initiated by
ligand-induced aggregation of FcǫRI-IgE complexes on mast cells and basophils. The model
is summarized in Fig. 1. The external stimulus in the model is constituted by a symmetric
bivalent ligand, such as a monoclonal anti-IgE, that cross-links two IgE molecules, each bound
to a FcǫRI receptor. We assume that aggregates of receptors are limited to dimers. The
tetrameric FcǫRI is modeled as three subunits, with the disulphide-bonded pair of γ chains
treated as one unit. The extracellular region of the α chain binds to the Fc portion of IgE.
The binding of IgE to the α subunit of the FcǫRI receptor is not explicitly considered, as the
half-life for the dissociation of the IgE-FcǫRI complex is much longer than the processes we
consider (Kulczycki & Metzger, 1974). We therefore ignore dissociation and treat the IgE-FcǫRI
complex as a single unit which we refer to as the receptor.
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Fig. 1. Components and states of the model, modified from Faeder et al. (2003). The bivalent
ligand is a monoclonal anti-IgE that can dimerize receptors.
The β subunit and the γ dimer contain the ITAMs that, upon phosphorylation, become
binding sites for the SH2 domains of the two kinases, Lyn and Syk. A simplifying assumption
of our model is that multiple tyrosine residues on receptor subunits and Syk are treated as
single units of phosphorylation, as indicated in Fig. 1a. For example, the separate tyrosines
in the β ITAM are lumped together, as are those in the γ ITAM, so that in the model an
ITAM is either phosphorylated or unphosphorylated. Sites of Syk tyrosine phosphorylation
are lumped into two units: the activation loop, which is phosphorylated by Syk, and the
linker region, which is phosphorylated by Lyn. Fig. 1b shows the states of the β chain
and the lumped γ chains included in the model. Each unit can be phosphorylated or
unphosphorylated, and can be associated with a kinase in any of several states. In the model,
each β chain and γ dimer can bind only a single kinase molecule at a time.
The model permits a large number of receptor states (Figs. 1b and 1c). Since the state of
each subunit is independent of the states of the other subunits, the total number of monomer
27athematical Model ng of Syk Activation in Allergen-Stimulated Mast Cells and Basophils
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states is nαnβnγ = 48. When a monovalent ligand is present as well as a bivalent ligand, the
number of monomeric states increases to 72. In a dimer, each subunit must be engaged with
the ligand, so the total number of dimer states is nβnγ(nβnγ + 1)/2 = 300. In addition, there
are six nonreceptor states, free ligand, free Lyn, and Syk in each of its four possible states of
phosphorylation, to yield a total of 354 distinct chemical species in the model. Our model is
composed of 354 chemical species and the 3680 chemical reactions that connect them. (For
details of the chemical reactions see Fig. 2 in Faeder et al. (2003).)
2.2 Network structure and parameters
The required input for the model are the rate constants associated with each of the reactions, as
well as the initial concentrations of each of the components, which are specific to the cell type
being modeled. We consider a bivalent allergen that differs from the ligand used by Faeder
et al. (2003) in that it binds reversibly to the receptor. Other than a different bivalent ligand,
the current reaction network is the same as in Faeder et al. (2003). Lyn can associate with
a receptor in a dimer in two possible ways, weakly with the unphosphorylated β chain of
the receptor and strongly to the phosphorylated β ITAM. Syk associates with FcǫRI through
an interaction between its tandem SH2 domains and the doubly phosphorylated γ ITAM.
Lyn, associated with a receptor aggregate, can transphosphorylate the β and γ ITAMs on an
adjacent receptor. In the model, all Lyn molecules available to the receptor are in an active
form. The available Lyn is considerably less than the total cellular Lyn. Syk is phosphorylated
in the model by either Lyn or Syk through transphosphorylation. Lyn phosphorylates Syk
tyrosines located in the linker region, while Syk phosphorylates the activation loop tyrosines.
Although Lyn may be responsible in vivo for a small portion of the Syk activation loop
phosphorylation, full Syk activation loop phosphorylation requires kinase-active Syk (Hong
et al., 2002).
In the model, phosphorylated units that are not protected through association with an SH2
domain can be dephosphorylated with a common rate constant, d, termed the intrinsic rate
constant for dephosphorylation. Dephosphorylation is blocked when an SH2 domain is
associated with the phosphorylated site. At long times, the model system goes to a steady
state, not an equilibrium. In the model, tyrosines are constantly being phosphorylated and
dephosphorylated. As a result, maintaining a constant level of phosphorylation requires a
constant input of energy. Since the modifications of the intracellular domains of the receptors
do not influence the extracellular binding, the distribution of ligand-receptor aggregates goes
to the same equilibrium as would be obtained if no chemical modifications occurred.
2.3 Implementation of rule-based modeling
The reaction rules and their associated rate constants were specified in the syntax of the
second-generation version of BioNetGen (Blinov et al., 2004; Faeder et al., 2009), which
uses graph theoretic methods to automatically generate the associated network of kinetic
balances (ordinary differential equations). The open-source software (available through
http://bionetgen.org) uses standard numerical algorithms to solve the generated system of
equations and obtain the time courses of all the species until the system attains a steady
state. In our simulations, all the kinetic parameters except the ones related to ligand binding
and unbinding are taken from Faeder et al. (2003), where a complete discussion of how the
parameters were obtained is given.
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3. The role of cellular FcǫRI and Syk expression levels in determining the Syk
activation response to extracellular stimulation of mast cells and basophils
In the current investigation we model the Syk dose-response curves in human basophils. A
broad distribution of Syk expression levels in human basophils, ranging from 5000 to 60,000
molecules per cell, has been reported in a recent survey (MacGlashan Jr, 2007). MacGlashan
and co-workers have observed that a low expression level of Syk attenuates the calcium
response (MacGlashan Jr & Lavens-Phillips, 2001), an event which is more proximal to Syk
activation in the signaling cascade than histamine release. Maximal histamine release from
human basophils shows a strong correlation with Syk activation (MacGlashan Jr, 2007). The
number of FcǫRI per human basophil varies from 1000 to 1000,000 with a typical value of
about 100,000 FcǫRI (MacGlashan Jr, 2007). Experimental observations (MacGlashan Jr, 2007)
suggest that the median Lyn expression level in human basophils is about 100,000 molecules
per cell. Using simulations of the detailed model, we examine the Syk activation curve for
different sets of receptor and Syk expression levels, keeping the available Lyn fixed at 100,000
per cell.
3.1 The shape of the Syk activation curve is predicted to depend on the abundance of Syk
relative to the number of FcǫRI
At equilibrium, the receptor cross-linking curve is always symmetric and bell shaped (Dembo
& Golstein, 1978). The shape of the Syk activation curve is predicted to depend on the
concentrations of Syk and FcǫRI receptors. The number of FcǫRI per human basophils varies
from 103 to 106 with a typical value of about 100,000 FcǫRI (MacGlashan Jr, 2007). The
corresponding Syk concentration ranges from 5× 103 to 6× 104 per cell (MacGlashan Jr, 2007).
At the lower boundary of the range (5× 103 Syk per cell), a receptor population of 7× 104 per
cell results in a predicted bimodal Syk activation curve (Fig. 2a). At the upper boundary
(6× 104 Syk per cell), the same level of receptors results in a bell-shaped Syk activation curve
(Fig. 2b).
In the model, full activation of a Syk molecule requires its transphosphorylation by a second
Syk, which occurs when two Syk molecules are bound to different receptors cross-linked by
a bivalent ligand. We refer to a receptor dimer with two bound Syk molecules, one on each
receptor, as a Syk dimer. Formation of Syk dimers is essential for Syk activation. Double
humped Syk activation curves are predicted to occur (Fig. 2a) if the concentration of receptors
dimers becomes sufficiently high that the number of receptor dimers with two Syks bound
decreases with increasing receptor dimer concentration.
Studies of histamine release dose response curves (log-log plots of the fraction of a cell’s total
histamine released in a given time versus the concentration of ligand the cell is exposed to)
lead to the definition of two types of inhibition of histamine release. In Type I inhibition,
commonly known as antigen excess inhibition, histamine release is inhibited when receptor
crosslinks are decreased. In the more interesting Type II inhibition, histamine release is
inhibited when receptor crosslinks are increased. This type of inhibition was first observed
by Becker et al. (Becker et al., 1973) who exposed human basophils to anti-IgE and found that
inhibition of histamine release was correlated with increased aggregation of IgE. Applying
the same terminology for Syk activation, Type I inhibition occurs in our model for parameter
regimes in which the number of Syk molecules is comparable to, or exceeds, the number
of receptors in dimers, so that the dose-response curve (Syk activation curve) follows the
27athematical Model ng of Syk Activation in Allergen-Stimulated Mast Cells and Basophils
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Fig. 2. Syk Activation curves for k+1 = 2.5× 106 M−1s−1, k+2 = 8× 10−9 cm2s−1,
k−1 = k−2 = 0.01 s−1, and [Lyn]tot = 105 per cell. Each curve corresponds to a different
number of receptors per cell given in the legend. The number of activated Syk molecules on
the y axis are given in numbers per cell. (a) [Syk]tot = 5× 103 per cell; (b) [Syk]tot = 6× 104
per cell. The number of activated Syk molecules on the y axis are the numbers per cell. In (a)
the ratio of total receptors to total Syk varies from 2-14 while in (b) the same ratio varies from
0.83-1.67.
receptor cross-linking curve at all the ligand concentrations (Fig. 3a). This type of inhibition
can be traced to the binding sites on IgE being blocked by the ligand at sufficiently high
concentrations, so that the number of receptor cross-links is reduced. Type II inhibition
in our model system results from an excess of FcǫRI-bound IgE dimers compared to the
number of available Syk molecules, and is characterized by decreasing signaling response
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(Syk activation) at ligand concentrations where receptor cross-linking is increasing. The
reduction in Syk activation, with increasing ligand concentration, near the center of the Syk
activation curve in Fig 3b is a Type II inhibition. Although we used a bivalent ligand in our
simulations to illustrate the two types of inhibition, the valence of the ligand is not critical as
long as it is multivalent.
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Fig. 3. Comparison of receptor cross-linking and Syk activation curves to determine the type
of antigen excess inhibition. k+1 = 2.5× 106M−1s−1, k+2 = 8× 10−9 cm2s−1,
k−1 = k−2 = 0.01 s−1; [Syk]tot = 5× 103 per cell; [Lyn]tot = 105 per cell. (a)
[FcǫRI]tot = 1× 104. The dashed line represents (Number of receptors in dimers)/20.0 and
the solid line represents the number of activated Syk molecules. (b) [FcǫRI]tot = 7× 104. The
dashed line represents (Number of receptors in dimers)/250.0 and the solid line represents
the number of activated Syk molecules.
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3.2 Effect of monovalent ligands on Syk activation
A way to distinguish between Type I and Type II inhibition is by comparing responses to
anti-IgE in the presence and absence of Fab fragments (Magro & Alexander, 1974; Magro
& Bennich, 1977). Adding monovalent ligand that competes for the same binding site as
a multivalent ligand will always reduce the number of cross-links. Thus, if the response
increases in the presence of monovalent ligand, the inhibition is Type II, while if it decreases
it is of Type I. To demonstrate, we have incorporated monovalent ligand into the model,
with the monovalent ligand having the same rate constants for binding and dissociation
as a single anti-IgE Fab site. The reference case we use for studying the effects of adding
monovalent ligands on the signaling response, measured by Syk activation in our model,
is characterized by the parameter values k−1 = k−2 = 0.01s−1, k+1 = 2.5 × 106 M−1 s−1,
k+2 = 8× 10−9 molecule−1 cm2 s−1 and total Syk, Lyn and FcǫRI numbers per cell of 5× 103,
1× 105 and 1× 105 respectively. We use this parameter set because it yields a bimodal Syk
activation curve in the absence of the monovalent ligand. We add monovalent ligand to a
maximum concentration of 6.6 nM which corresponds to 4 × 106 molecules per cell. We
consider the effects of adding monovalent ligands on Syk activation at two bivalent ligand
concentrations, 2×10−5 nM and 2×10−3 nM, corresponding to 2K1L values of 10−5 and 10−3
respectively. Fig. 4 shows that adding monovalent IgE ligand in increasing concentrations
leads to a gradual lowering in the Syk activation level at 2K1L = 10
−5 (Type I inhibition). In
contrast, adding monovalent ligand in increasing concentrations at 2K1L = 10
−3 results in a
gradual increase of the Syk activation level (Type II inhibition).
On plotting the Syk activation level as a function of the added monovalent ligand
concentration for two values 10−5 and 10−3 of 2K1L, we obtain Fig. 4b which is qualitatively
similar to the plot of histamine release as a function of the amount of added monomer
anti-IgE (Fab) in Fig. 1 of Ref (Magro & Alexander, 1974) as shown in Fig. 4c. The
similarity between the predicted variation of Syk activation and the experimentally observed
variation of histamine release (Goldstein & Wofsy, 1994; Magro & Alexander, 1974) with
added monomer concentration suggests one possible mechanism for Type II inhibition.
3.3 A symmetric cross-linking curve can lead to an asymmetric Syk activation curve
For the ligand-receptor binding parameters in Table 1, and FcǫRI and Syk concentrations of
1× 105 and 7× 103 per cell respectively, we observe a Syk activation curve with two prominent
maxima at 2K1L = 10
−4 and 2K1L = 104 (Fig. 5a). This parameter set is used because it
accentuates the asymmetry between the two maxima. The extent of receptor cross-linking
at these two ligand concentrations are equal. The mean lifetime of the receptor dimer is
independent of the ligand concentration, which implies that kinetic proofreading effects at
these two ligand concentrations should be identical. Still, in the steady state, the model
predicts that there is greater Syk activation at the lower ligand concentration (2K1L = 10
−4),
than at the higher (2K1L = 10
4).
Even though all signaling events are initiated by receptor aggregation, it appears that the
concentrations of free and bound receptors which are not in aggregates influence signaling.
To investigate the origin of the asymmetry, we vary both the the ligand-IgE association
(k+1) and dissociation (k−1) constants, such that the corresponding equilibrium constant K1,
and therefore the equilibrium cross-linking curve, remains unchanged. If the ligand-IgE
dissociation constant is gradually reduced from 0.3 (10−0.5) to 0.0003 (10−3.5)s−1, the Syk
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Fig. 4. (a)The effect of adding different concentrations of a monovalent IgE ligand on the
extent of Syk activation at 2K1L = 10
−5 (Syk activation increases with 2K1L) and at
2K1L = 10
−3 (Syk activation decreases with 2K1L). The concentration of monovalent
inhibitor (Fab fragments when the ligand is anti-IgE) present in the simulation is given in the
figure. (b) The variation of the extent of Syk activation as a function of the concentration per
cell of a monovalent inhibitor, I, at two ligand concentrations given by 2K1L = 10
−5 and
2K1L = 10
−3. The ligand-receptor binding parameters used are k+1 = 2.5× 106 M−1s−1,
k+2 = 8× 10−9 cm2s−1, k−1 = k−2 = 0.01s−1. [Syk]tot = 5× 103 per cell; [Lyn]tot = 105 per
cell; [FcǫRI]tot = 10
5 per cell. (c) Modified Figure 1 from Magro and Alexander (Magro &
Alexander, 1974). Plot of histamine release due to 5× 10−10 M anti-IgE (A) and 5× 10−8 M
(B) incubated with increasing concentrations of monomer anti-IgE (Fab). The insert shows
the positioning on the dose response curve of the two anti-IgE concentrations.
activation at 2K1L = 10
−4 remains practically unaltered, whereas the Syk activation at
2K1L = 10
4 increases and approaches the extent of Syk activation at 2K1L = 10
−4 (Fig. 5b).
On the other hand, if the ligand-IgE dissociation constant is increased from 0.3 to 103 s−1,
the Syk activation at 2K1L = 10
4 remains unchanged and that at 2K1L = 10
−4 decreases and
approaches the Syk activation level at 2K1L = 10
4 for k−1 = 0.3 s−1 (Fig. 5c). In order to
determine the source of asymmetry in the Syk activation curve, we consider a pair of reduced
models, which are discussed in the following section.
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Fig. 5. (a) Syk Activation curve for k+1 = 2.5× 107 M−1 s−1; k+2 = 8× 10−9cm2s−1;
k−1 = 0.316(10−0.5) s−1; k−2 = 0.0316(10−1.5)s−1; (b)-(c) Syk Activation curves for
k+2 = 8× 10−9cm2s−1; k−2 = 0.0316(10−1.5)s−1; (b)The k+1 and k−1 values are varied such
that K1 = k+1/k−1 is fixed at 7.9 ×107 M−1. The legends show the k−1 values used and the
k+1 values are accordingly adjusted so that K1 remains fixed. For parts (a), (b) and (c),
[Syk]tot = 7× 103 per cell; [Lyn]tot = 105 per cell; [FcǫRI]tot = 105 per cell.
3.4 Reduced models of Syk binding to cross-linked receptors
We consider two reduced models, 1 and 2, where the kinetic effects involving Lyn and the
β subunit of the receptor have been eliminated. Both models correspond to the limit where
the available Lyn is in large excess. In model 1, cross-linked receptors transphosphorylate
each other on the γ subunit with a transphosphorylation rate that is the same as that of
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Parameter Description Value(s)
k+1 ligand-receptor binding forward rate constant 2.5× 107M−1s−1
k−1 ligand-receptor binding reverse rate constant 0.316(10−0.5)s−1
k+2
ligand-receptor cross-linking forward rate
constant
8.0× 10−9 cm2mole−1s−1
k−2 ligand-receptor cross-linking reverse rate constant 0.0316(10−1.5)s−1
Table 1. Ligand-receptor binding parameters which accentuate the asymmetry in the Syk
activation curves. Other rate constants used in our calculations are taken from Faeder et al.
(2003). The bimolecular rate constants k+1 and k+2 are divided by the inverse cell density
(1.0×10−6 ml) and the cell surface area (8.0×10−6 cm2) to convert them to unimolecular rate
constants.
Lyn bound through it SH2 domain to the phosphorylated β subunit of the receptor. As in
the full model, bound Syk protects the γ subunit from being dephosphorylated. The rate
of dephosphorylation of unprotected phosphorylated γ subunits is the same as in the full
model. As seen in Fig. 6a, model 1 exhibits an asymmetry in a plot of Syk dimer formation as
a function of the log of the ligand concentration.
In model 2, in addition to assuming Lyn is in excess, all receptor γ subunits are always
phosphorylated, thereby eliminating the kinetic effects of receptor phosphorylation. This
corresponds to the additional limit that the rate of receptor dephosphorylation goes to zero.
For example, if in the full model, the available Lyn is increased from 105 to 108 per cell and
the rate constant for dephosphorylation reduced from 20 s−1 to 10−4 s−1, then a plot of Syk
dimer formation for the full model and model 2 are identical (Fig. 6b). When this second
assumption is made, the asymmetry in the Syk dimer curve is eliminated, indicating that the
kinetics of phosphorylation and dephosphorylation of the γ subunit plays a role in creating
the asymmetry.
3.5 The asymmetry in Syk activation originates from asymmetry in Syk dimer formation.
Since model 1 captures the asymmetry in Syk activation predicted by the full model, we use it
to analyze the source of asymmetry in Syk dimer formation. As shown in Fig. 7b for model 1,
one can form a Syk dimer (d0) in a number ways. We have obtained expressions for the mean
time required by any particular Syk molecule to end up in a Syk dimer, starting as either
cytosolic Syk or as part of a complex with other molecule(s).
3.5.1 Mean time for a Syk molecule to enter into a Syk dimer
We calculate for reduced model 1, the mean times taken by a particular (tagged) Syk molecule
to end up in a Syk dimer (Syk-FcǫRI-Ligand-FcǫRI-Syk) starting as either free Syk or as part of
a Syk containing complex other than the Syk dimer. In Fig. 7a, we assign notations to different
Syk containing species in the reduced model. The mean time taken to form a Syk dimer from
species i is given by τi. The kinetic parameters used are described in Table 2. We define the
mean time of incorporation of the tagged Syk molecule in species d0, starting from species i, in
the following fashion. This mean time is divided into two parts, the first part corresponding
to the mean time of transition from species i to all other species containing the tagged Syk
molecule. This is the inverse of the sum of rates of all processes that transform species i to the
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Fig. 6. Comparison of number of Syk dimers per cell obtained using reduced model 1 and 2,
with the corresponding numbers obtained using the full model. [Syk]tot = 7× 103 per cell;
[FcǫRI]tot = 10
5 per cell. We use the same ligand-receptor and Syk-pγ binding and
unbinding parameters as in Table 2 for both the reduced models and the full model. (a) We
consider two different total cellular concentrations of Lyn in the full model, [Lyn]tot = 10
5
and [Lyn]tot = 10
6 per cell. (b) Comparison of reduced model 2 to the full model when Lyn is
in large excess and the rate of dephosphorylation is negligible ([Lyn]tot = 10
8 per cell,
k−p = 10−4s−1).
other species. The second part represents the mean remaining time to incorporate the tagged
Syk in the Syk dimer species d0. In terms of the species from Fig. 7a and the kinetic parameters
from Table 2, the mean times of transition from species a0, b0, c0, c1 and s0 respectively.
ma0 =
1
k+2(b0 + b1 + b2) + k−1 + k−S
(1)
mb0 =
1
k+2(a0 + a1 + a2) + 2k+1L + k−S
(2)
mc0 =
1
2k−2 + k−S + k−p + k+Ss0
(3)
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Fig. 7. (a) Schematic representation of the different Syk containing species in the reduced
model 1. We tag a particular Syk molecule and calculate the mean time required by this Syk
molecule to be incorporated into a Syk dimer (d0). (b) (i-v) shows the different routes by
which a tagged Syk molecule can be transferred from one species to another. (c) Mean time
τSyk taken by any particular Syk molecule to be incorporated into a Syk dimer, starting as
cytosolic Syk (s0) or as other specie(s) (a0, b0, c0, c1) in (a). The rate parameters are taken from
Table. 2. [Syk]tot = 7× 103 per cell; [FcǫRI]tot = 105 per cell.
mc1 =
1
2k−2 + k−S + k+p
(4)
ms0 =
1
k+S(a1 + b1 + 2d1 + c0 + e0)
(5)
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Parameter Description Value(s)
k+1 ligand-receptor binding forward rate constant 2.5× 107M−1s−1
k−1 ligand-receptor binding reverse rate constant 0.316(10−0.5)s−1
k+2 ligand-receptor cross-linking forward rate constant 8.0× 10−9 cm2mole−1s−1
k−2 ligand-receptor cross-linking reverse rate constant 0.0316(10−1.5)s−1
k+gP receptor γ phosphorylation forward rate constant 3.0 s
−1
k−gP receptor γ dephosphorylation rate constant 20s−1
k+S Syk-phosphorylated receptor γ binding forward rate constant 6.0× 10−5 molecule−1s−1
k−S Syk-phosphorylated receptor γ reverse rate constant 0.13s−1
Table 2. Kinetic parameters used in reduced model with receptor γ
phosphorylation-dephosphorylation. The bimolecular rate constants are divided by the
inverse cell density (1.0×10−6 ml) and the cell surface area (8.0×10−6 cm2) to convert them
to unimolecular rate constants.
In terms of the above quantitites, τi can be defined as follows.
τa0 = ma0[1 + (k+2b1τc0 + k+2b2τc1 + k−1τb0 + k−Sτs0)] (6)
τb0 = mb0[1 + (k+2a1τc0 + k+2a2τc1 + 2k+1Lτa0 + k−Sτs0)] (7)
τc0 = mc0[1 + (k−2τa0 + k−2τb0 + k−Sτs0 + k−pτc1)] (8)
τc1 = mc1[1 + (k−2τa0 + k−2τb0 + k−Sτs0 + k+pτc0)] (9)
τs0 = ms0[1 + (k+Sa1τa0 + k+Sb1τb0 + 2k+Sd1τc0 + k+Se0τc1)] (10)
The above equations are solved for τa0, τb0, τc0, τc1 and τs0 using parameters from Table 2 for
different L values corresponding to log10(2K1L) values from -8 to 8. The expression levels of
Syk and FcǫRI receptor per cell are taken as 7×103 and 105 respectively. The mean time for
any tagged Syk molecule to be incorporated into a Syk dimer (d0) is given by
τSyk = pa0τa0 + pb0τb0 + pc0τc0 + pc1τc1 + ps0τs0 (11)
where
pa0 = a0/[Syk]tot; pb0 = b0/[Syk]tot; pc0 = c0/[Syk]tot;
pc1 = c1/[Syk]tot; ps0 = s0/[Syk]tot
(12)
and [Syk]tot = a0 + b0 + c0 + c1 + 2d0 + s0. The quantity τSyk is plotted as a function of
log102K1L in Fig. 7c. This mean time τSyk is not symmetric with respect to reflection about
2K1L = 1. The mean time at 2K1L = 10
−4 is less than its counterpart at 2K1L = 104, as shown
in Fig 7c.
3.6 The asymmetry in Syk activation depends on the receptor-ligand dissociation constant
In Fig. 8a, we vary k−1 and k+1 keeping their ratio K1 fixed, and calculate the average time
τSyk required by a Syk to end up in a Syk dimer. At k−1 = 10−3.5 s−1, the τSyk values at
2K1L = 10
−4 and 2K1L = 104 are close to each other, so that there is little difference in the
extent of Syk activation at these two ligand concentrations as was seen in Fig. 5b. As k−1
is increased from 10−3.5 s−1, τSyk at 2K1L = 10−4 remains unchanged while τSyk at 2K1L =
104 increases. This is consistent with our results from the full model, that Syk activation at
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2K1L = 10
−4 is essentially unchanged, while Syk activation at 2K1L = 104 decreases as k−1
is increased and K1 is kept fixed (Fig. 5b). The difference between the τSyk values at the two
ligand concentrations increases, as does the asymmetry in Syk activation obtained using the
full model. When k−1 is increased beyond 0.316 (10−0.5) s−1, τSyk at 2K1L = 10−4 increased
while τSyk at 2K1L = 10
4 reaches a plateau. As a result, the difference in the τSyk values at
these two ligand concentrations decreases with increasing k−1. As k−1 is increased to 103
s−1, τSyk at both 2K1L = 10−4 and 2K1L = 104 approaches the same value. This is the same
trend exhibited by Syk activation in the full model (Fig. 5c). The strong correlation between
τSyk from reduced model 1 and Syk activation in the full model supports the idea that the
asymmetry in the Syk activation profile originates from the asymmetry in τSyk.
The question remains, how can the kinetics of ligand binding, which occurs on the outside of
the cell, give rise to an asymmetry in the Syk activation curve, when the receptor cross-linking
curve is symmetric? To answer the question we considered two receptors, one free and
one bound. These receptors might, for example, have come from a receptor dimer when it
dissociated and their cytoplasmic domains may be associated with Syk or Lyn or both. We
show how to calculate two quantities at equilibrium, τR and τB, the mean times respectively
of an unbound receptor to enter into an aggregate and for a bound receptor that is not
cross-linked to a second receptor to enter into an aggregate (Fig. 9a).
3.6.1 Mean time for a receptor to enter into a receptor dimer
We consider the case the cross-linking of monovalent receptors by a bivalent ligand. There
are two possible transitions an unbound receptor can undergo. It can interact with a bound
receptor to form a dimer or it can bind to a ligand in solution to become a bound receptor.
Similarly two transitions are possible for a bound receptor that is not in an aggregate. It can
associate with a free receptor to form a dimer or it can detach from its ligand and become a
free receptor. These transitions are illustrated in Fig. 9a where the rates of transition are given.
The mean times τR and τB will be found by solving two linear algebraic equations that are
functions of the equilibrium concentrations of the free receptors, R, and the bound receptors
not in dimers, B. At equilibrium, these concentrations are calculated from the single site
equilibrium constants for binding and crosslinking, K1 and K2 respectively, and the total
receptor and ligand concentrations, RT and LT . However, for our purposes, it is more useful
to express the results in terms of the free ligand concentration.
If there are RT total receptors on the cell surface and there are no processes that remove or add
new receptors the the total number of receptors is conserved and
RT = R + B + 2D = R + 2K1LR + 2(2K1L)(K2/2)R
2
= (1 + 2K1L)R + 2K1K2LR
2 (13)
where D is the concentration of receptor dimers. Defining r = R/RT as the fraction of free
receptors Eq. (13) becomes
1 = (1 + 2K1L)r + 2K1K2RT Lr
2 (14)
It can be shown that w, the fraction of receptors not in dimers is given by
w = (1 + 2K1L)r =
−1 +√1 + 4δ
2δ
(15)
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Fig. 8. Variation with k−1 of (a) average time (τSyk) required by any particular Syk molecule
to end up in a Syk dimer and (b) minimum time (τ
(R)
min) required by a receptor to be
incorporated into a receptor dimer, at ligand concentrations given by 2K1L = 10
−4 and
2K1L = 10
4. The k−1 and k+1 are varied in such a way that K1 = k+1/k−1 remains fixed at
7.9 ×107 M−1. Other rate constants are taken from Table 2. [Syk]tot = 7× 103 per cell;
[FcǫRI]tot = 10
5 per cell.
where
δ =
2K1K2RT L
(1 + 2K1L)2
(16)
It follows that
R = wRT
1
1 + 2K1L
(17)
B = wRT
2K1L
1 + 2K1L
(18)
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Fig. 9. (a) Rate constants that characterize the transitions that a free receptor and a bound
receptor not in an aggregate can undergo. (b) The mean times for a free receptor (τR) and a
bound receptor (τB) to find a partner and form a dimer as functions of the bivalent ligand
concentration. (c) The mean τave of τR and τB and the minimum τ
(R)
min of τR and τB as a
function of the ligand concentration. In parts (b) and (c), the ligand receptor binding and
cross-linking parameters are taken from Table 2 and [FcǫRI]tot = 10
5 per cell.
We next write down the equations for the mean times.
τB =
1
k+2R + k−1
+
k−1
k+2R + k−1
τR (19)
τR =
1
k+2B + 2k+1L
+
2k+1L
k+2B + 2k+1L
τB (20)
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The first term in each equation is the mean time to make a transition, while the second term
is the mean remaining time after the first transition until the receptor is incorporated into a
dimer. We define the following quantities:
t1 =
1
k+2R + k−1
t2 =
1
k+2B + 2k+1L
(21)
p1 =
k−1
k+2R + k−1
p2 =
2k+1L
k+2B + 2k+1L
(22)
The ts are mean times to make a transition while the ps are probabilities of making specific
transitions.
Eqs. (19) and (20) hold whether or not the system is in equilibrium. At equilibrium, there
are simplifications. For example, at equilibrium, p1 = p2, i.e., the probability of a ligand
dissociating from a bound receptor is equal to the probability of a free receptor binding a
ligand. This must be so if equilibrium is to be maintained. Solving Eqs. (19) and (20), we have
τB =
t1 + p1t2
1− p1 p2
(23)
τR =
t2 + p2t1
1− p1 p2
(24)
3.6.2 Asymmetry in Syk activation profile results from differential minimum time for a
receptor to reform a dimer at different ligand concentrations
In Fig. 9b we show the mean times τR and τB as functions of the bivalent ligand concentration.
Neither are symmetric, nor is their minimum, although their sum is symmetric (Fig.9c).
Monovalent binding is responsible for the asymmetry. Consider the mean times at two free
ligand concentrations, L+ and L−, where log(2K1L+) = − log(2K1L−). At L−, the bound
receptor gets incorporated into a dimer more rapidly than the unbound receptor because it
is present in the lowest concentration, and so it more rapidly finds a partner to crosslink.
At L+ the opposite is true. The asymmetry that arises in the minimum time for a receptor
to reform a dimer, τ
(R)
min , results from an asymmetric effect of the free ligand concentration
on the lifetime of the minority receptor (the receptor at lowest concentration). At high ligand
concentrations, minority receptors (unbound) are rapidly converted to bound receptors giving
them less time to enter into a dimer. Thus, they may have to undergo interconversion between
unbound and bound forms many times before forming a dimer. At low ligand concentrations,
the initial conversion of the minority receptors (bound) to the unbound form is independent
of the ligand concentration, depending only on the rate of dissociation.
In Fig. 8b we keep the equilibrium constant K1 = k+1/k−1 fixed and, for the same set of
parameters as in Fig. 8a, vary k−1. We observe that the dependence of τ
(R)
min on log10(k−1/s
−1)
at the two ligand concentrations given by 2K1L = 10
−4 and 2K1L = 104 is qualitatively similar
to that of τSyk. Since receptor dimerization is upstream from, and necessary for Syk activation,
we infer that the dependence of τSyk on k−1 results from the corresponding dependence of τ
(R)
min
on k−1.
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4. Serial engagement of IgE-FcǫRI complexes can enhance Syk activation in mast
cells
As we have mentioned earlier in this chapter, mast cell responses mediated by FcǫRI are
initiated when a multivalent ligand, an allergen for example, aggregates the receptors. In
order to maintain the cellular response, it is not required that new aggregates constantly form.
Kent et al. (Kent et al., 1994) exposed RBL cells to covalently cross-linked oligomers of IgE
for a short duration and then added excess monomeric IgE to prevent further aggregation of
receptors. Under these conditions, aggregated receptors continued to propagate the cellular
signal. Phosphorylation of the β and γ immunoreceptor tyrosine-based activating motifs
(ITAMs), phosphorylation of the protein tyrosine kinase Syk, and the release of histamine
containing granules were sustained for substantial lengths of time after new aggregate
formation was blocked. Although serial engagement of IgE-FcǫRI complexes is not necessary
for mast cell signaling, the question still remains whether serial engagement can enhance mast
cell response at low allergen concentrations. After deriving an expression for the rate at which
a ligand of valence N serially engages receptors on a surface, we have refined this question
and used the model of Faeder et al. (2003) to answer it.
4.1 Extension of mathematical model to simulate Syk activation in RBL cells stimulated by
trivalent ligands
Earlier in this chapter, we have discussed how the model of Faeder et al. (2003) has been
used to simulate the early response of RBL cells to the addition of a reversible bivalent ligand
that binds to, and dimerizes, IgE-Fc complexes on RBL cell surfaces. The model consists
of a network of 354 distinct chemical species connected by 3680 chemical reactions, 21 rate
constants and three concentrations, the surface concentrations of FcǫRI and available Lyn,
and the total concentration of Syk. With the exception of the rate constants that describe the
interaction of the bivalent ligand with IgE, k+1, k−1, k+2 and k−2, the parameters used in the
simulations are the same as those given in Table I of Faeder et al. (2003). In the simulations for
the current investigation, we take koff = k−1 = k−2 and the total concentrations of Lyn, Syk
and FcǫRI are specific for RBL cells.
We now generalize our model to simulate the early signaling events triggered by the addition
of a symmetric trivalent ligand with three identical binding sites interacting with IgE bound
to FcǫRI on RBL cells. There is now an additional surface crosslinking reaction involving a
trivalent ligand with two of its sites bond crosslinking a third IgE-FcǫRI, described by rate
constants k−3 and k+3. In the simulations, we take koff = k−1 = k−2 = k−3 and k+2 = k+3.
It is assumed that a Lyn bound to a receptor can randomly transphosphorylate any other
receptor in the aggregate with the same rates, as it was assumed for the dimeric aggregate.
For the trivalent ligand, the model expands to 2954 distinct chemical species connected by
49948 reactions.
4.2 Theory
First, we obtain an expression for the rate of serial engagement of a multivalent ligand of
valence N binding to free mobile receptors on a cell surface that has a concentration of R
free receptors. This expression allows us to choose parameter values that define ligands with
different rates of serial engagement. We then use these parameter values to simulate the early
response of mast cells to ligands that serial engage receptors at different rates. We use as our
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measure of signaling response, receptors that have fully activated Syk associated with their
γ ITAMs. Syk becomes partially active upon binding through its two SH2 domains to the
doubly phosphorylated γ ITAM (Shiue et al., 1995). In our model, Syk is fully active when
it has been transphosphorylated on its activation loop tyrosines by a second Syk (reviewed
in Faeder et al. (2003)). Finally, we use the results of the simulations to evaluate the role of
serial engagement in early responses of mast cell signaling.
4.2.1 Serial engagement of a N-valent ligand
The rate of serial engagement equals the number of receptors the ligand encounters from the
time ta it first attaches to a cell surface receptor until the time tb when its last bond breaks,
divided by the time this process lasted, tb − ta. Figure 10 illustrates the reactions a five valent
ligand can undergo once it is initially bound to a receptor on a surface. The mean time an
N-valent ligand, that initially has one site bound to a receptor, remains on a surface when the
concentration of free receptors is R is (Hlavacek et al., 2002; 1999)
tN =
1
koff
[ (1 + K2R)N − 1
NK2R
]
(25)
where K2 = k+2/koff is the equilibrium cross-linking constant.
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Fig. 10. The multiple reactions a ligand of valence five (N = 5) can undergo from the time it
first binds a cell surface receptor until the last ligand-receptor bond breaks and the ligand
leaves the surface. R is the concentration of free receptors. In these reactions, k+2 is the
single-site rate constant for addition of a receptor to a ligand-receptor complex and koff is the
corresponding reverse rate constant. By taking all the forward and reverse rate constants to
be the same, we have assumed that these rate constants are independent of the bound state
of the ligand.
In the following section, we derive the following expression for nN , the mean number of
receptors an N-valent ligand that initially has one site bound to a receptor, serial engages
before it dissociates from the cell surface.
4.2.2 Average number of receptors serially engaged by a multivalent ligand
An expression for the average number of receptors a multivalent ligand serially engages, nN ,
is obtained by solving a set of ordinary differential equations (ODEs). We consider a cell with
monovalent receptors on its surface that is in equilibrium with a homogeneous concentration
of N-valent ligands. At equilibrium, there is a distribution of bound ligands, some with one
site bound, some with two sites bound, up to some with N sites bound. We consider the
92 Advances in Prot in Kinases
www.intechopen.com
Mathematical Modeling of Syk Activation in Allergen-Stimulated Mast Cells and Basophils 23
ensemble of N-valent ligands that, at t = 0, have one and only one site bound to a receptor.
We let Bi(t) be the fraction of these ligands that have i sites bound at time t or equivalently,
the probability that a ligand has i sites bound at time t when initially it had one site bound.
We keep track of the number of receptors a ligand serial engages by keeping track of how
many receptors dissociate from a ligand until the ligand leaves the cell surface. Since the rate
at which a receptor dissociates from a ligand with i sites bound is ikoff, the averaged number
of receptors a ligand will serial engage from the time it binds to the cell until the time it leaves
the cell is:
nN = koff
∫ ∞
0
(
2B2(t
′) + 3B3(t′) · · ·+ NBN(t′)
)
dt′ (26)
Before solving the general problem, we illustrate our approach by finding the number of
receptors a bivalent ligand serial engages during its time on the cell surface.
The equilibrium concentration of free receptors we call R. For a bivalent ligand, we have the
following set of ODEs:
dB1
dt
= −koffB1 − k+2RB1 + 2koffB2 (27)
dB2
dt
= k+2RB1 − 2koffB2 (28)
The initial conditions are that B1 = 1 and B2 = 0.
The average number of receptors a bivalent ligand engages during its time on the cell surface
is
n2 = 2koff
∫ ∞
0
B2(t
′)dt′ (29)
As is standard, we use Laplace transforms (L), to transform the problem into solving a set of
algebraic equations, taking s to be the transform variable and B¯i(s) = L[Bi(t)]. Note that
nN = lim
s→0
koff
(
2B¯2(s) + 3B¯3(s) · · ·+ NB¯N(s)
)
(30)
This follows because the Laplace transform of
∫ t
0 f (u)du is f¯ (s)/s and
lim
t→∞
g(t) = lim
s→0
sg¯(s) (31)
Taking Laplace transforms of both sides of Eqs. (27) and (28), we have
sB¯1 − B1(0) = −koffB¯1 − k+2RB¯1 + 2koffB¯2
sB2 = k+2RB¯1 − 2koffB¯2
We can take the limit before we solve the equations. Setting s = 0, k = k+2R/koff = K2R and
B1(0) = 1,
1
koff
= (1 + k)B¯1 − 2B¯2
0 = kB¯1 − 2B¯2
Solving, we have that B2 = k/(2koff) and
n2 = lim
s→0
koff2B2(s) = k = K2R (32)
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For a ligand with valence N,
dBi
dt
= (i + 1)koffBi+1 + (N − i + 1)k+2RBi−1 − ikoffBi − (N − i)k+2RBi (33)
Bi can appear through dissociation of a receptor from any of i + 1 receptor-occupied sites
of Bi+1, which corresponds to a term (i + 1)koffBi+1, and through engaging of a receptor by
any of (N − (i− 1)) free sites of Bi−1, which corresponds to a term (N − i + 1)k+2RBi−1. Bi
can disappear by losing a receptor from any of its i receptor-bound sites and by adding a
receptor to any of (N − i) free sites, which corresponds to substraction of terms ikoffBi and
(N − i)k+2RBi respectively.
Putting k = k+2R/koff, τ = kofft, B0 = BN+1 = 0, and collecting terms,
dBi
dτ
= (i + 1)Bi+1 − (i + k(N − i))Bi + k(N − i + 1)Bi−1, i = 1, . . . , N (34)
(Note that B0 = BN+1 = 0 implies that the corresponding Laplace transforms B¯0 = B¯N+1 =
0.)
As before, taking Laplace transforms and setting the transform variable equal to zero, we
obtain
−1 = 2B¯2 − (1 + k(N − 1))B¯1
0 = 3B¯3 − (2 + k(N − 2))B¯2 + (N − 1)kB¯1
0 = 4B¯4 − (3 + k(N − 3))B¯3 + (N − 2)kB¯2
...
0 = −NB¯N + kB¯N−1
First, we solve this system of equations for B¯1 by summing all the equations:
−1 =
N
∑
i=1
(
(i + 1)B¯i+1 − (i + k(N − i))B¯i + k(N − i + 1)B¯i−1
)
=
N
∑
i=2
iB¯i −
N
∑
i=1
(i + k(N − i))B¯i +
N−1
∑
i=1
k(N − i)B¯i
=
N
∑
i=1
(
i− (i + k(N − i)) + k(N − i))B¯i − B¯1
Each term in the sum on the right hand side equals zero, so that B¯1 = 1. To find B¯2, we sum
up all equations except the first one:
0 =
N
∑
i=2
(
(i + 1)B¯i+1 − (i + k(N − i))B¯i + k(N − i + 1)B¯i−1
)
=
N
∑
i=3
iB¯i −
N
∑
i=2
(i + k(N − i))B¯i +
N−1
∑
i=1
k(N − i)B¯i
=
N
∑
i=2
(
i− (i + k(N − i)) + k(N − i))B¯i − 2B¯2 + k(N − 1)B¯1
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K2R = 0.1 K2R = 1.0 K2R = 10.0
N kofftN nN rNk
−1
off kofftN nN rNk
−1
off kofftN nN rNk
−1
off
2 1.05 0.10 0.095 1.50 1.00 0.67 6.00 10.00 1.67
3 1.10 0.21 0.190 2.33 3.00 1.29 44.33 120.00 2.71
4 1.16 0.33 0.285 3.75 7.00 1.87 366.00 1330.00 3.63
5 1.22 0.46 0.380 6.20 15.00 2.42 3221.00 14640.00 4.55
Table 3. The influence of the parameter K2R (the product of the equilibrium cross-linking
constant and the free receptor concentration) on the mean time a N-valent ligand remains
bound to the surface (tN), the mean number of receptors the ligand engages while it remains
bound to the surface (nN), and the rate the ligand serial engages receptors (rN). Increasing
K2R increases the rate at which a ligand cross-links a receptor compared to the rate at which
a receptor dissociates from the ligand.
Again, the first sum on the right hand side equals zero so that B¯2 = k(N − 1)B¯1/2 = k(N −
1)/2. Similarly, B¯3 = k(N − 2)B¯2/3 = k2(N − 1)(N − 2)/(1 · 2 · 3). Following this approach,
it is straightforward to show that
B¯j = k
j−1 (N − j + 1)(N − j + 2) . . . (N − 1)
j!
= kj−1
(N − 1)!
j!(N − j)! (35)
and therefore, that
nN =
N
∑
j=2
jB¯j =
N
∑
j=2
kj−1
(N − 1)!
(j− 1)!(N − j)! (36)
4.2.3 Average rate of serial engagement
The average rate, rN , an N-valent ligand serially engages receptors is
rN = nN/tN (37)
In Table 3 we evaluate these expressions for N = 1− 5 and K2R = 0.10, 1.0 and 10.0. The
parameter K2R is the product of the surface equilibrium cross-linking constant and the surface
concentration of free receptors. Larger values of K2R favor aggregate formation. Note that for
large values of K2R, as the valence is increased, the number of serial engagements and the
mean time the ligand remains bound to the cell rises rapidly but their ratio, the rate of serial
engagement, increases only modestly. From Eqs (25)-(37) it can be shown that the maximal
rate of serial engagement achievable by an N-valent ligand when koff is fixed and k+2R is
increased is Nkoff. When k+2R is fixed and koff is increased, the maximal rate is k+2R.
4.2.4 The rates of serial engagement of receptors for bivalent and trivalent ligands
We now focus on bivalent and trivalent ligands interacting with monovalent receptors. From
Eqs. (25) - (37) we have that the rate of serial engagement of a bivalent ligand
r2 = 2koff
K2R
2 + K2R
(38)
A second way this result can be obtained is to note that one receptor is bound and released
by a bivalent ligand in one cycle time tc so that r2 = 1/tc. The cycle time is the sum of the
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mean times for a site on a doubly bound ligand to open and for the singly bound ligand to
bind to another receptor, i.e., tc = 1/(2koff) + 1/(k+2R). (When the ligand is a pMHC rather
than a bivalent ligand the two in Eq. (38) becomes a one (Wofsy et al., 2001).) This simple
approach for calculating r2 cannot easily be generalized to ligands with valence greater than
two because for these ligands, there is more than one recycling time.
From Eqs. (25) - (37), we have the rate of serial engagement of a trivalent ligand
r3 = 3koff
2K2R + (K2R)
2
3 + 3K2R + (K2R)2
(39)
It is easy to see from these expressions that for large values of K2R, the rate of serial
engagement approaches its maximal value of Nkoff. We use Eqs. (38) and (39) to pick the
parameter values that characterize the ligands for our simulations.
There are three separate ways to vary the ligand properties to enhance serial engagement,
increase koff, increase k+2 or increase the valence of the ligand:
1. Increasing koff enhances the rate at which the ligand serial engages receptors but this has the
deleterious effect of enhancing kinetic proofreading by reducing the time a receptor remains
in an aggregate. Once a receptor leaves an aggregate, unless it can rapidly enter into a new
aggregate, all modifications it has undergone will be reversed and it will return to its basal
state (Mao & Metzger, 1997; Peirce & Metzger, 2000).
2. Increasing k+2 reduces the time it takes a free site on a ligand in a ligand-receptor complex
to bind to a new receptor. This enhances the effects of serial engagement by making it more
likely that a ligand-receptor complex will form a new dimer before the ligand dissociates and
the receptor returns to its basal state.
3. Increasing the valence of the ligand has a similar effect to increasing the forward rate
constant. For an N-valent ligand bound through a single site to a receptor, the forward rate
of binding a second receptor and forming a dimer is proportional to (N − 1)k+2. However,
increasing the valence introduces other effects as well. A higher valent ligand can form larger
aggregates and large aggregates are more effective at signaling than smaller aggregates, even
when the ligands are oligomers of IgE that do not undergo serial engagement (Fewtrell &
Metzger, 1980). In RBL cells, Lyn, the kinase that is responsible for ITAM phosphorylation,
is limiting (Torigoe et al., 1997; Wofsy et al., 1997). Therefore, larger aggregates have a higher
probability than receptor dimers of containing a receptor associated with Lyn, and a Lyn in an
aggregate can serial phosphorylate all its neighboring receptors in the aggregate.
4.3 Simulations of mast cell responses to bivalent and trivalent ligands for different rates
of serial engagement
We use our model to assess the role of serial engagement in mast cell signaling. The predicted
outputs of the model that we use in our study are the concentrations (number per cell)
of the phosphorylated β and γ ITAMs of FcǫRI, and the concentration of Syk bound to a
phosphorylated γ ITAM and transphosphorylated on its activation loop tyrosines by a Syk
bound to an adjacent receptor. We refer to Syk bound to the γ ITAM and phosphorylated on
its activation loop tyrosines as fully activated Syk or phosphorylated Syk. Using antibodies
specific for phosphorylated tyrosines in the activation loop of Syk, it has been shown that
upon FcǫRI aggregation, these tyrosines became phosphorylated and this phosphorylation
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depended on the kinase activity of Syk (Zhang et al., 2000). The presence of these activation
loop tyrosines are necessary for Syk-mediated propagation of FcǫRI signaling (Zhang et al.,
1998).
4.3.1 Increasing serial engagement by increasing koff reduces Syk activation
In Figure 11 we compare the predicted levels of β and γ ITAM phosphorylation and full
Syk activation induced by four different hypothetical ligands, two bivalent (circles) and two
trivalent (squares), that have the same single site forward rate constants k+2 = 2.0× 10−11
cm2/s. (In the simulations, we take the surface area of the cell A = 8× 10−6 cm2 and the
total number of receptors per cell NT = 4× 105 so that the receptor density RT = 5× 1010
cm−2. Therefore, at low ligand concentrations, when most of the receptors are free so
that R ≈ RT , the rate at which a bound ligand with one site free cross-links a receptor is
k+2R = 1.0 s
−1.) Each pair of bivalent and trivalent ligands have dissociation rate constants
koff = 0.01 s
−1 (solid lines and symbols) and 10 s−1 (dashed lines and open symbols). For
the dimer, increasing koff from 0.01 s
−1 to 10 s−1 corresponds to increasing the rate of serial
engagement from r2 = 0.017 s
−1 to 0.10 s−1 (Eq. 38), while for the trimer, the increase is from
r3 = 0.027 s
−1 to 0.20 s−1 (Eq. 39). In addition to increasing the rate of serial engagement,
increasing koff reduces the lifetime of the bond between a site on the ligand and a receptor
site and thus, increases the effects of kinetic proofreading (McKeithan, 1995). As previously
discussed (Faeder et al., 2003), to equalize the comparison, the levels of phosphorylation are
plotted as a function of the number of receptors in aggregates. Figure 11a shows the ligand
concentrations needed to achieve the same level of receptor aggregation for the different
ligands. As koff is increased while keeping k+2RT fixed, for both bivalent and trivalent ligands,
a higher ligand concentration is required to yield the same number of aggregated receptors,
since the rate at which the receptor cross-link is broken is enhanced, whereas the rate at which
the cross-links form remains unaltered. In Figure 11d we see that as the lifetime of a receptor in
an aggregate is decreased, i.e., koff is increased, full Syk activation is dramatically reduced for
both bivalent and trivalent ligands. Kinetic proofreading dominates any positive effects serial
engagement may have on Syk activation. This result is similar to that seen in experiments
using fast and slowly dissociating multivalent ligands that aggregate IgE on RBL cells (Torigoe
et al., 1998).
Figure 11b and Figure 11c show that the proximal signaling events, β and γ ITAM
phosphorylation, compared with Syk phosphorylation, are effected less by the changes in the
ligand-receptor lifetime as expected from a kinetic proofreading model (McKeithan, 1995).
The reduction in Syk phosphorylation is pronounced because it is much further down the
signaling cascade than phosphorylation of the receptor γ-chain. A number of reversible steps
must occur to go from γ-chain phosphorylation to Syk phosphorylation. A Syk molecule
has to bind to a phosphorylated γ-chain before the γ-chain is dephosphorylated. For
transphosphorylation of the γ-bound Syk molecule to occur, a second Syk molecule must
bind, which requires a second γ-chain to be phosphorylated in the same aggregate. Finally,
transphoshorylation among the Syk molecules must occur before either of the Syk molecules
dissociates.
4.3.2 Increasing serial engagement by increasing k+2 increases Syk activation
In Figure 12 we compare the levels of β and γ ITAM phosphorylation and full Syk activation
induced by four different hypothetical ligands, two bivalent (circles) and two trivalent
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Fig. 11. Simulation of the effects of increasing the rate of serial engagement of bivalent and
trivalent ligand by increasing the ligand-receptor dissociation constant, koff. The four curves
correspond to k+2RT = 1.0 s
−1 and bivalent (circles) and trivalent (squares) ligands with
koff = 0.01 s
−1 (solid lines and symbols) and 10 s−1 (dashed lines and open symbols). The
additional parameters used in the simulations are given in Table I of Faeder et al. (2003). The
x-axis indicates levels of FcǫRI aggregation, given as the number of receptors per cell in
aggregates. One percent of the cell’s receptors in aggregates corresponds to 4× 103 receptors.
(A) Free ligand concentrations corresponding to specified levels of receptor aggregation. (B),
(C), and (D) are respectively the predicted number of receptors per cell with the β ITAM
phosphorylated, the γ ITAM phosphorylated, and Syk bound to the phosphorylated γ ITAM
and transphosphorylated on its activation loop by another Syk.
(squares), that have the same dissociation rate constant koff = 0.1 s
−1 and different surface
cross-linking constants. Each pair of bivalent and trivalent ligands have surface cross-linking
constants such that k+2RT = 0.1 s
−1 (solid lines and symbols) and 100 s−1 (dashed lines and
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open symbols). As in Figure 11, we compare ligands at different concentrations that result
in the same number of receptors being in aggregates at equilibrium. Since koff is fixed, the
lifetime of a receptor in an aggregate is the same for all four ligands. As k+2RT is increased
from 0.1 s−1 to 100 s−1, the rate of serial engagement for the bivalent ligand increases from
0.067 s−1 to 0.20 s−1 (Eq.(38)), and for the trivalent ligand from 0.13 s−1 to 0.30 s−1 (Eq.(39)).
(These rates of serial engagement were calculated for low ligand concentrations, when R ≈ RT
and k+2R ≈ k+2RT .) We see that the simulations predict that increasing the rate of serial
engagement while holding koff fixed has a minor effect on receptor phosphorylation (12b
and c), but a more pronounced effect on the phosphorylation of Syk by Syk, i.e, on full Syk
activation (12d).
4.3.3 Increasing the valence of a ligand increases Syk activation, partly as a result of
increased serial engagement
From Eqs. (38) and (39) we can calculate the increase in the rate of serial engagement as a
result of increasing the valence of a ligand from two to three while keeping its rate constants
unchanged. The factor by which the rate of serial engagement increases, r3/r2, depends only
on the parameter k+2R, and monotonically decreases from 2 to 3/2 as k+2R increases from
zero to infinity. In Figure 13, as in 12, we compare the predicted full Syk activation from
simulations where the stimulating ligand is either bivalent (circles) or trivalent (squares), the
rate of serial engagement is varied by varying k+2, and for both ligands, the lifetime of a
receptor bound to a ligand is the same, 10 s (koff = 0.10 s
−1). The range over which the rate
of serial engagement varies in Figure 13 corresponds to k+2R = 0.01 − 100 s−1. In Figure
13a, the two top curves and two bottom curves correspond to 1000 and a 100 receptors per
cell in aggregates. For the same rate of serial engagement and the same number of receptors
in aggregates, the model predicts that the trivalent ligand is more effective than the bivalent
ligand at activating Syk.
In Figure 13b, we re-plot the simulations for the upper two curves in Figure 13a. To illustrate
how we can asses the contribution of serial engagement in enhancing Syk phosphorylation
of Syk when the valence is increased, we consider the point labeled 1 on the Syk activation
curve for the bivalent ligand in Figure 13b. This point corresponds to the serial engagement
rate for a bivalent ligand with k+2R = 0.01 s
−1 and koff = 0.10 s−1 . When the valence is
increased from two to three with the rate constants unchanged, the rate of serial engagement
for the trimer increases above that of the dimer to the point on the trivalent ligand curve
labeled 2. We see that there would be an increase in Syk phosphorylation of Syk for a trivalent
ligand even if there was no increase in the rate of serial engagement. This is indicated by
the difference B-A on the y-axis and is a result of effects other than serial engagement. The
increase in Syk activation that is attributable to the increase in serial engagement is indicated
by the difference C-B on the y-axis, which can be substantial.
Lyn is strongly regulated by Cbp and Csk (Kawabuchi et al., 2000; Ohtake et al., 2002) on
RBL cells and as a result, the amount of Lyn available to the receptor is in short supply
(Torigoe et al., 1997; Wofsy et al., 1997). Although Lyn regulation is not in the model, the Lyn
concentration available to the receptor is chosen so that Lyn is limiting. In the model, in the
absence of the ligand, less than five percent of the receptors are associated with Lyn which is
consistent with the observations of Yamashita et al. (Yamashita et al., 1994). Upon aggregation,
large receptor aggregates are more likely to contain a Lyn than small receptor aggregates, and
once a Lyn is in an aggregate it can transphosphorylate all receptors in its proximity. It is
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Fig. 12. Simulation of the effects of increasing the rate of serial engagement of bivalent and
trivalent ligand by increasing the rate of crosslinking, k+2R. The four curves correspond to
koff = 0.1 s
−1 and bivalent (circles) and trivalent (squares) ligands with k+2R = 0.1 s−1 (solid
lines and symbols) and 100 s−1 (dashed lines and open symbols). All other parameters are
the same as in Figure 11. The x-axis indicates levels of FcǫRI aggregation, given as the
number of receptors per cell in aggregates. (A) Free ligand concentrations corresponding to
specified levels of receptor aggregation. (B), (C), and (D) are respecitively the predicted
number of receptors per cell with the β ITAM phosphorylated, the γ ITAM phosphorylated,
and Syk bound to the γ ITAM and transphosphorylated by Syk on its activation loop.
these effects that the model captures when the valence of the ligand is increased from two
to three and that account for the increase in Syk phosphorylation that is not a result of serial
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Fig. 13. Predicted number of activated Syk (Syk transphosphorylated by Syk) as a function of
the rate of serial engagement. (A) The circles refer to bivalent ligand simulations and the
squares to trivalent ligand simulations. Open and solid symbols refer to 1000 and 100
receptors in aggregates respectively. (B) Replot of the bivalent and trivalent curves in (A) for
1000 receptors in aggregates. The symbol 1 corresponds to a dimer with k+2R = 0.01 s
−1 and
koff = 0.10 s
−1. The symbol 2 corresponds to a trimer with the same rate constants. A = 100,
B = 161 and C = 290 activated Syk per cell. The net increase in activated Syk, (C− A) is 190
Syk per cell, of which C− B = 129 Syk per cell can be attributed to serial engagement.
engagement. We investigate this further by considering ligands that cannot serial engage
receptors.
4.3.4 Serial engagement is not necessary for Syk activation
Although the aggregation of FcǫRI is an absolute requirement for mast cell signaling mediated
by FcǫRI, serial engagement is not, as has been demonstrated using oligomers of IgE (Kent
et al., 1994). As a test of our model, we have carried out simulations with bivalent and
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trivalent oligomers of IgE considered as ligands, taking the dissociation rate constant koff = 0,
which ensures that there is no serial engagement. (Since the half-life for dissociation of
an IgE-Fcǫ complex is close to a day (Kulczycki & Metzger, 1974), this is an excellent
approximation in simulating experiments that last a few hours or less.) The predicted results
for γ-phosphorylation and Syk activation for IgE dimers and trimers at one hour are shown
in Figures 14a and 14b. These results are compared to histamine release dose response curves
for RBL-2H3 cells exposed to IgE oligomers for one hour. Because of the slow forward rate
constant for IgE binding to FcǫRI (Wofsy et al., 1995), equilibrium is achieved at one hour
only for IgE concentrations greater than about 5 μg/ml. The simulations indicate that to
achieve measureable histamine release from RBL cells requires the activation of substantial
numbers of Syk molecules. For example, the simulations predict that 10% histamine release
with trivalent ligands, about 25% of maximal release, occurs when approximately 10,000 Syk
are fully activated.
5. Discussion
Mutivalent ligands (allergens) bind to, and aggregate, IgE complexed with FcǫRI receptors
expressed on the surface of mast cells and basophils. We have used a generalized version
of the model of Faeder et al. (2003) of the early cell signaling events (seconds to minutes)
mediated by the cross-linking of IgE-FcǫRI complexes to study the dependence of the
activation of Syk on the cellular concentrations of Syk and IgE-FcǫRI complexes and to
investigate the role of serial engagement in Syk activation. The model was originally
developed for covalently cross-linked dimers of IgE binding to FcǫRI on the surface of RBL
cells (Faeder et al., 2003). For bivalent ligands binding reversibly to IgE-FcǫRI complexes,
the model applies when IgE acts as a monovalent receptor. We restrict the use of the model
to concentrations of bivalent ligands for which the binding of two ligands to one IgE is
negligible. In the model, full activation of Syk can only occur when two Syk molecules
are bound to a receptor dimer formed by a bivalent ligand. A Syk molecule becomes fully
activated when it is transphosphorylated on its activation loop tyrosines (Tyr518 and Tyr519 in
murine Syk) by a Syk bound to the adjacent receptor in the dimer. Using antibodies specific
for phosphorylated tyrosines in the activation loop of Syk, Zhang et al. (Zhang et al., 2000)
showed that upon FcǫRI aggregation, these tyrosines became phosphorylated and the extent
of phosphorylation depended on the kinase activity of Syk. Further, the presence of these
activation loop tyrosines was necessary for Syk-mediated propagation of FcǫRI signaling
(Zhang et al., 1998). Syk is capable of phosphorylating its activation loop tyrosines both
in vitro (Tsang et al., 2008; Zhang et al., 2000) and in vivo Zhang et al. (2000), but it is still
unresolved whether transphosphorylation (phosphorylation of one Syk molecule by another
in the same complex) or autophosphorylation (phosphorylation of a Syk molecule by the
kinase domain of the same molecule) is the mechanism by which the Syk activation loop
tyrosines are phosphorylated in mast cells and basophils.
If the mechanism of Syk activation is Syk transphosphorylation of Syk, as postulated
by Faeder et al. (2003), the Syk activation curve can be either bell-shaped or double-humped,
depending on the cellular concentrations of Syk and IgE-FcǫRI complexes (see Figure 2). On
the other hand, if Syk activation is achieved via autophosphorylation, the model predicts that
only a bell-shaped Syk activation curve is possible. In the model, it is assumed that because
of steric hindrance only one Syk molecule can bind per receptor, even though there are two
disulfide-linked γ-chains that, when fully phosphorylated, present two binding sites for Syk.
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Fig. 14. Predicted γ and Syk phosphorylation, and measured RBL-2H3 cell degranulation, for
dimeric and trimer oligomers of IgE. In (A) and (B) the circles refer to IgE dimer simulations
and the squares to IgE trimer simulations. The rate constants characterizing the oligomers
are taken to be koff = 0 s
−1, k+1 = 8× 104 M−1 s−1 and k+2RT = 100 s−1. The simulations
correspond to exposure of the ligands to RBL-2H3 cells for one hour. (C) Experimentally
determined degranulation of RBL-2H3 cells after one hour of exposure to either dimers or
trimers of IgE (Fewtrell & Metzger, 1980).
If two Syk can be bound simultaneously to the same receptor on two separate γ-chains, and
if they can transphosphorylate each other to achieve full Syk activation, the prediction is still
that Syk activation curves can be either bell-shaped or double humped depending on the ratio
of the receptor to Syk concentrations.
Unfortunately, at present there are no experimentally-determined Syk activation curves to
help us distinguish among possible mechanisms for the phosphorylation of the Syk activation
loop tyrosines. If we look further downstream than Syk activation at histamine release
from basophils, which requires kinase active Syk, the data are consistent with the Syk
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transphosphorylation mechanism. For example, although most histamine release curves
show only a single maximum, double-humped histamine release curves have been observed
(Delisi & Siraganian, 1979; Weyer et al., 1982). (Histamine release curves are plots of the
fraction of a cell’s total histamine that is released in a given time versus the logarithm of the
concentration of ligand the cell is exposed to.) In addition, for ligand concentrations where
receptor aggregate formation is high and histamine release low, the addition of monovalent
hapten, which reduces the number of receptors in dimers, increases histamine release (Magro
& Alexander, 1974; Magro & Bennich, 1977). In model simulations, the same manipulation
increases Syk activation (Figure 4).
To study the properties of Syk activation, we performed simulations over a range of ligand
concentrations for different Syk and receptor concentrations. From the simulations we found
that even though the receptor cross-linking curve was symmetric with respect to the log of the
ligand concentration in the steady state (Figure 15), the Syk activation curve often was not.
This was easiest to see when the Syk activation curve was doubled-humped (Figure 5). The
asymmetry in the steady state occured when, at two different ligand concentrations yielding
identical total numbers of receptors in dimers and identical lifetimes of a receptor in a dimer,
the levels of Syk activation differed. This was puzzling since all that differed on the cell
surface at the two ligand concentrations was the number of receptors bound monovalently.
Why should this matter since basophils and mast cells don’t respond to monovalently bound
ligand? The answer is subtle and concerns the competition between kinetic proofreading, that
activation requires the receptor to undergo multiple binding and chemical modification events
while the receptor is in an aggregate, and serial engagement, that ligands can bind multiple
receptors before dissociating from the cell surface.
Once a receptor dimer breaks up, the two receptors, one with a ligand attached and the
other free, will diffuse away from each other. If Syk or Lyn is bound to the receptors, these
kinases will dissociate with half-lives of about ten seconds, leaving behind unprotected ITAM
phosphotyrosines to be rapidly dephosphorylated. Thus, the receptors would return to their
basal state. If, however, a receptor can re-form a dimer before it has been transformed
back to its basal state, it can partially compensate for the effects of kinetic proofreading.
The asymmetry in the Syk activation curve arises because the minimum time required by
a receptor to form a dimer is dependent on the free ligand concentration (Figure 9). At low
ligand concentration, and therefore low numbers of bound receptors, a singly bound receptor
will collide with many free receptors and have ample opportunity to rapidly form a dimer.
At high ligand concentration, and therefore low numbers of free receptors, a free receptor
will have many bound receptors to collide with, but, because the free ligand concentration is
high, the free receptor may bind a ligand from solution before it has time to form a dimer.
Thus, at low ligand concentration, re-formation of dimers is more effective than at high
ligand concentration at reducing the effects of kinetic proofreading. In our simulations, the
double-humped Syk activation curves (Figure 5) show that Syk activation can be higher at the
first maximum (at the lower ligand concentration) than at the second maximum (at the higher
ligand concentration) where the extent of receptor cross-linking is the same at both maxima.
To further probe the underlying mechanism of the asymmetry in the Syk activation curve, we
considered our model in the limit when Lyn is in large excess and γ-ITAM phosphorylation
follows immediately upon dimer formation. In this limit, simulations again showed an
asymmetry in the double-humped Syk activation curve (Fig.6a). Since for full Syk activation
to occur, a Syk dimer (Syk-FcǫRI-ligand-FcǫRI-Syk) must form, we calculate the mean time
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Fig. 15. Receptor cross-linking (dimerization) curve for k+1 = 2.5× 107 M−1 s−1;
k+2 = 8× 10−9cm2s−1; k−1 = 0.316(10−0.5) s−1, k−2 = 0.0316(10−1.5) s−1. The receptor
aggregation is maximum at L = 1/2K1, i.e. at log10(2K1L) = 0, where K1 = k+1/k−1 is the
equilibrium constant for the extracellular bivalent ligand, present at concentration L, for
binding to the Fab part of the IgE.
for a Syk molecule that is not in a Syk dimer to be incorporated into a Syk dimer. The time for
this to occur showed a similar asymmetry as that of the minimum time for a receptor to enter
a dimer. It appears that the asymmetry in the Syk activation curve is a manifestation of the
underlying competition that is constantly occurring between kinetic proofreading and serial
engagement in signaling cascades triggered by multivalent ligands aggregating cell surface
receptors.
The asymmetry we observed in simulations of Syk activation curves was always small.
Although the explanation of the effect is interesting, whether it is ever important in cell
signaling is an open question. Since amplifications of cell signals can be highly nonlinear, it
is possible that small differences in the concentration of activated kinases early in a signaling
cascade can have profound effects on later cell responses.
A major function of activated Syk in mast cells and basophils is to phosphorylate a set of
tyrosines on the transmembrane adapter protein LAT (linker for the activation of T cells).
LAT’s three distal tyrosines, when phosphorylated, all bind the adapter protein Grb2, and
Grb2 mediates the aggregation of LAT (Houtman et al., 2006). The size of the LAT aggregates
that form depends strongly on whether or not all three of the Grb2 binding site tyrosines
are phosphorylated (Nag et al., 2009). It remains to be seen whether small differences in the
amount of activated Syk can lead to large differences in the distribution of LAT aggregates
that form downstream of Syk.
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The model prediction of differential Syk activation at low and high extracellular ligand
concentrations, which arises from differential compensation by serial engagement for the
effects of kinetics proofreading at the two ligand concentrations, has led us to explore in
greater detail, the role of serial engagement in enhancing Syk activation in mast cells and
basophils. When surface densities of receptors are sufficiently high, multivalent ligands can
bind to cell surfaces and serial engage numerous receptors before dissociating, i.e., before
all of the ligand’s binding sites are simultaneously free. Even with a valence as low as two, a
ligand can engage multiple receptors from the time it first attaches to the surface until the time
it dissociates (see Table 3). A single binding site on a ligand may bind a receptor, dissociate
from it, and repeat the cycle with a new receptor multiple times before the ligand leaves the
surface.
Using our detailed mathematical model, we have investigated the role of serial engagement
of FcǫRI in mast cell signaling. We use the model for low concentrations of the multivalent
ligand so that the binding of two ligands to one IgE is negligible. For the purpose of
exploring the role of serial engagement in enhancing Syk activation, we have included in
our model, cross-linking reactions between a trivalent ligand and an IgE-FcǫRI complex. The
concentration of receptors is chosen to be high enough that there is a significant population
of free receptors so that serial engagement is favored. A basic assumption of the model is
that when a ligand is bound to more than one receptor and a bond opens, the freed receptor
diffuses away before the site on the ligand can rebind to it. This is a reasonable assumption
as long as receptors remain mobile on the cell surface. Receptors in small aggregates on
the RBL cell surface remain mobile (Andrews et al., 2009), but not the receptors in large
aggregates (Andrews et al., 2008; Menon et al., 1986). We expect serial engagement to be
significantly reduced and exert little effect on cell signaling when the surface receptors are
immobile. We have only considered the case when receptors remain mobile and our results do
not apply to large aggregates where receptors are immobile. The expression we have derived
for the rate of serial engagement for a ligand of valence N, Eq. (37), holds only when receptors
are mobile.
We considered three ways in which serial engagement could be enhanced: by increasing the
rate at which a ligand binding site dissociates from a receptor; by increasing the rate at which
a free site on a ligand that is bound to a receptor can cross-link another receptor; and by
increasing the valence of the ligand. Model simulations showed that increasing the rate of
serial engagement by increasing the rate of dissociation reduced the concentration of activated
Syk (see Figure 11d). Increasing the rate of dissociation of a ligand-receptor bond decreases
the lifetime of a receptor in an aggregate and accentuates the effect of kinetic proofreading.
The further down the signaling pathway an event occurs, the more pronounced are the effects
of kinetic proofreading on the event, as can be seen by comparing the predicted γ-chain
phosphorylation (Figure 11c) with the predicted Syk phosphorylation (Figure 11d). The
positive effects serial engagement has on signaling are outweighed by kinetic proofreading
when the lifetime of the ligand-receptor bond is decreased(McKeithan, 1995; Torigoe et al.,
1998).
Simulations predict that increasing the rate at which cross-linking occurs, while keeping
the lifetime of the bond between a ligand site and receptor constant, so as not to enhance
kinetic proofreading, increases Syk activation. In Figure 13a, a single curve corresponds to a
series of bivalent or trivalent ligands with increasing rates of serial engagement achieved by
increasing cross-linking constants. The ligands have the same dissociation rate constants and
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Fig. 16. At low ligand concentration, when most receptors are unbound, a receptor-ligand
complex that dissociates from an aggregate (1), can rapidly enter a new aggregate (2),
provided that the rate of cross-linking is greater than the rate of dissociation of its
ligand-receptor bond. If this is not the case the ligand-receptor complex will be rapidly
converted to a free receptor, reducing it chance of quickly finding a binding partner.
their concentrations have been chosen so that they aggregate the same number of receptors
on the cell surface, yet the faster the ligands are able to serial engage receptors, the more Syk
they are able to activate. This model prediction supports the hypothesis used to explain the
previously discussed asymmetric Syk activation profile, that serial engagement can partially
nullify the effects of kinetic proofreading by allowing receptors that have dissociated from
an aggregate to enter new aggregates before they fully return to their basal state. Previously
we estimated that when a receptor leaves an aggregate its unprotected phosphotyrosines are
dephosphorylated in less than a second, and any Syk or Lyn that are bound to phosphorylated
ITAMS dissociate with half-lives of the order of 10-15 seconds (Faeder et al., 2003). Even
within an aggregate, phosphorylation and dephosphorylation is constantly occurring (Kent
et al., 1994). If a receptor can enter into a new aggregate before all the modifications it has
undergone have been reversed, full activation of Syk will be more efficient.
As depicted in Figure 16 for a bivalent ligand at low concentration, a receptor that remains
bound to a ligand when an aggregate breaks up is much more likely to be rapidly incorporated
into a new aggregate than a receptor with its binding site free, provided the rate for
cross-linking a new receptor is equal to, or faster than the rate of dissociation of the
ligand-receptor bond, i.e., k+2R ≥ koff, or equivalently K2R ≥ 1. Even when this condition
on the rate constants is met, serial engagement can only partially compensate for the effects of
kinetic proofreading since free receptors that leave an aggregate will most likely return to the
basal state before they form new aggregates.
The model also predicts that increasing the valence of a ligand from two to three, while
keeping the rate constants the same, increases Syk activation (Figure 13). We have derived
expressions for the rates of serial engagement of dimers and trimers, Eqs. (38) and (39), which
show that increasing the valence while keeping all other quantities fixed raises the rate of
serial engagement. However, the predicted increase in Syk activation is not solely due to
the increase in serial engagement. Both experiment (Fewtrell & Metzger, 1980) and the model
predictions (Figure 14) indicate that trimeric oligomers of IgE are more effective than dimers at
activating RBL cells, even though these ligands cannot serial engage receptors. This is because
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Lyn is limiting in RBL cells, with most receptors not associated with a Lyn (Torigoe et al.,
1997; Wofsy et al., 1997; Yamashita et al., 1994). Large aggregates are more likely than small
aggregates to have a Lyn bound to a receptor in the aggregate and initiate signaling. Further,
the larger the aggregate, the higher is the number of receptors that can be phosphorylated
by a single Lyn. Serial engagement can further accentuate this signaling. We have estimated
the additional contribution to Syk activation from the increase in serial engagement when a
trivalent ligand is substituted for a bivalent ligand and shown that it can be substantial (Figure
13b).
Ligand-induced receptor aggregation initiates a chemical cascade that involves chemical
reactions that build and use transient molecular scaffolds. Upon aggregation of FcǫRI on mast
cells, the cytoplasmic domains of the receptor become sites for the coalescence of the kinases
Lyn and Syk, with Syk undergoing rapid activation by phosphorylation. The activated Syk
phosphorylates conserved tyrosines on adaptor molecules such as LAT to form scaffolding
molecules. However, the structures formed around the cytoplasmic domains of the receptor,
as well as other scaffolding proteins, are ephemeral with components going on and off
rapidly. How successful this construction will be depends on the lifetime of a receptor in
an aggregate. If the lifetime is too short, most of the chemical cascades that are initiated
will not go to completion, and signaling will be dampened or completely prevented. This
is the idea behind kinetic proofreading (reviewed in (Goldstein et al., 2008)), introduced in
the context of cell signaling by McKeithan (McKeithan, 1995), and kinetic proofreading has
highlighted the role of the pMHC-TCR bond dissociation rate constant in T-cell signaling.
We have used a mathematical model of the initial steps in the chemical cascade triggered
by FcǫRI aggregation on mast cells to investigate the role of serial engagement in signaling,
and shown that for a series of ligands with the same dissociation rate constant, increasing
the forward rate constant for cross-linking, or increasing the ligand valence increases serial
engagement and Syk activation. Serial engagement is able to partially reverse the effects of
kinetic proofreading and enhance mast cell signaling.
6. Conclusion
Faeder et al. have developed detailed mathematical model of the early signaling events, up
to and including Syk activation, that are triggered when IgE-FcǫRI complexes are exposed
to a bivalent or trivalent ligand on rat basophilic leukemia (RBL) cells. We have used
this model to investigate the effect of cellular Syk and FcǫRI concentrations on the level
of Syk activation. Using model simulations, we show that for a subset of physiological
FcǫRI and Syk concentrations, differences in total extracellular ligand concentration can lead
to subtle kinetic effects that yield qualitative differences in the levels of Syk activation.
Since these kinetic effects arise from differential serial engagement rates at different ligand
concentrations, we have assessed the contribution of serial engagement to Syk activation in
mast cells and basophils, and shown that for a series of ligands with the same dissociation
rate constant, increasing the forward rate constant for cross-linking, or increasing the ligand
valence increases serial engagement and Syk activation. Serial engagement is able to partially
reverse the effects of kinetic proofreading and enhance mast cell signaling. To summarize, we
review in this chapter, our research directed at determining the possible factors that influence
the levels of Syk activation in mast cells and basophils. Syk activation is a crucial step in
the signal transduction cascade in mast cells and basophils that gives rise to the allergic
response in individuals. An in-depth understanding of the strength of the signal transduced
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via this biochemical network, and its underlying kinetics, will be of immense assistance in
a network level approach for design of allergy drugs that targets multiple molecules in the
signal transduction cascade.
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